Company intelligence / Profile preview

SLE Enterprises

Unknown, Unknown, Unknownsle-enterprises.com ↗

Ownership: Private
Development stage: Other

Overview

SLE Enterprises has developed and commercialized a patented method for liquid encapsulation that is plastic-free and scalable. The technology is designed to serve multiple industries including pharmaceuticals and nutraceuticals by providing high-throughput, flexible core-shell combinations without microplastic waste. Their system can produce up to 1.5 million capsules per hour with significant energy cost reductions compared to traditional methods.

Modalities: Small moleculeBiologicNutraceuticalsPharmaceuticals
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on SLE Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLE Enterprises.

Explore the full profile